Agenus (AGEN) Stock: Buy, Sell, or Hold?
AGEN - Agenus Inc.
$6.94
0.05 (0.73%)
▲
5d:
-15.78%
30d:
+0.58%
90d:
+104.72%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When AGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: AGEN is down 15.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: AGEN is down 15.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: AGEN is currently trading at $6.94, which is considered oversold relative to its 30-day fair value range of $7.06 to $8.10. From a valuation perspective, the stock is trading at a discount (Forward PE: -115.7) compared to its historical average (5.1). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AGEN is in a strong uptrend. Immediate support is located at $6.66, while resistance sits at $8.38.
Market Sentiment: AGEN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.50 (+181.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AGEN is in a strong uptrend. Immediate support is located at $6.66, while resistance sits at $8.38.
Market Sentiment: AGEN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.50 (+181.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.06 -
$8.10
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
Protect Your Profits
Holding AGEN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 181.0% below Wall St target ($19.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.06 -
$8.10
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.66
Resistance Level
$8.38
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-115.67
Wall Street Target
$19.50
(+181.0%)
Revenue Growth (YoY)
34.4%
Profit Margin
69.3%
PE vs Historical
-115.7 vs 5.1
CHEAP
Share & Embed Analysis
Last updated: September 13, 2026 7:21 PM ET
Data refreshes hourly during market hours. Next update: 8:21 PM
Data refreshes hourly during market hours. Next update: 8:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 45 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 55 HOLD |
|
JSPR
Jasper Therapeutics Inc |
STRONG BUY
11 analysts |
$7 | 62 BUY |
|
RLAY
Relay Therapeutics Inc |
STRONG BUY
13 analysts |
$27 | 64 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 44 HOLD |
Advanced AGEN Option Strategies
Professional options setups generated by AI based on today's AGEN price and gamma walls.
